Gland Pharma Limited — Shareholders meeting

Gland Pharma Limited has submitted its scrutinizers' report and voting results to the stock exchange following a postal ballot. This document confirms the outcome of the votes cast by shareholders on specific agenda items, providing official confirmation of the resolutions that were approved or rejected.

This update is a routine corporate governance procedure that ensures transparency and compliance with listing regulations. For investors, it marks the formal conclusion of the voting process and signals that the company is moving forward with the approved decisions. It does not change the company's fundamental business operations or financial outlook.

Investors should now monitor the company's official announcements for any further disclosures related to the passed resolutions. Since the voting process is now complete, the focus will shift to the execution of these decisions and their impact on the company's future strategy.